Irvine-based Broadcom Corp.’s shares are set to stay on Nasdaq as the chipmaker works through a review of its stock option grants.
Nasdaq officials want an update on Broadcom’s review by Jan. 7 and hope to see the company’s recently missed quarterly filings with the Securities and Exchange Commission by Jan. 31.
Broadcom hasn’t filed its last two quarterly results because of its ongoing probe into option grants.
In July, Broadcom said it was likely to restate more than five years of earnings to account for the timing of stock options, which the company started looking into in May.
In September, the company said it expects the cost of its restatement to top $1.5 billion, twice as much as first thought in July.
